SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ProMetic Life Sciences
An SI Board Since April 2016
Posts SubjectMarks Bans Symbol
250 11 0 PLI.TO
Emcee:  axial Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
125This is an informative thread on the Stockhouse board. Recommended reading. Jiaxial-9/19/2017
124Leo, thanks for your courteous reply. With Prometic, it often seems there's axial-9/17/2017
123Jim thanks for keeping this going! I am still long on PLI. Patience will be keLeo Fisher-9/16/2017
122Morgan Stanley Global Healthcare Conference Monday, September 11 Listen at — caxial-9/11/2017
121The waiting game continues. Despite the share price decline, there's been noaxial-9/11/2017
120PROMETIC TO PRESENT AT TWO U.S. INVESTOR CONFERENCES IN SEPTEMBER LAVAL, QUEBEaxial-9/8/2017
119What Other Types of Vouchers Exist? ' So far, two other types of voucher eaxial-8/29/2017
118PROMETIC RECEIVES RARE PEDIATRIC DISEASE DESIGNATION FROM U.S. FDA FOR ITS PLASMaxial18/29/2017
117PROMETIC REPORTS 2017 SECOND QUARTER HIGHLIGHTS AND FINANCIAL RESULTS $101 milliaxial-8/14/2017
116Blood agency seeking $855-million in funding to boost plasma supply, document reaxial-8/14/2017
115PROMETIC AND SHENZHEN ROYAL ASSET MANAGEMENT CLOSE TRANSACTION FOR JOINT VENTURaxial-8/14/2017
114PROMETIC TO REPORT ITS SECOND QUARTER 2017 FINANCIAL RESULTS AND TO HOLD CONFEREaxial-8/8/2017
113PROMETIC ANNOUNCES POSITIVE LONG TERM CLINICAL DATA ON RYPLAZYMTM IN PLASMINOGEaxial-7/11/2017
112FDA outlines ‘Innovation Initiative,’ Cures plans to speed up drug development axial-7/10/2017
111Email from Pierre Laurin [ Original here. — *Note*— IMO, after years of readingaxial-7/10/2017
110Response from Fred Dumais re: current status ... content edited for clarity. Oaxial-7/7/2017
109PROMETIC ANNOUNCES CLOSING OF EQUITY OFFERINGS FOR AGGREGATE GROSS PROCEEDS OF $axial-7/6/2017
108Gottlieb's Aggressive Plans to Streamline the Orphan Drug Review Process &axial-6/22/2017
107Well that's disappointing! In that last CC, as I heard it, in response toCush16/15/2017
106PROMETIC ANNOUNCES $53 MILLION BOUGHT DEAL OFFERING 'LAVAL, QUEBEC, CANADA axial-6/15/2017
105NEW DATA PRESENTED BY PROMETIC AT ADA’S SCIENTIFIC SESSIONS VALIDATES PBI-4050axial-6/12/2017
104From an MD/Prometic investor ... Intensive Care Off Label Indications ' Fraxial15/23/2017
103PROMETIC PRESENTS NEW DATA ON PBI-4050 AND PLASMINOGEN AT THE AMERICAN THORACIC axial-5/23/2017
102Must see — excellent presentation. CIBC Technology & Innovation Conferenceaxial-5/18/2017
101PROMETIC REPORTS 2017 FIRST QUARTER HIGHLIGHTS AND FINANCIAL RESULTS $69.3 milliaxial-5/16/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News